Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Rev Gastroenterol Mex (Engl Ed) ; 84(4): 492-510, 2019.
Artículo en Inglés, Español | MEDLINE | ID: mdl-31564473

RESUMEN

The present review of noncaloric sweeteners (NCSs) by the Asociación Mexicana de Gastroenterología was carried out to analyze and answer some of the most frequent questions and concerns about NCS consumption in patients with gastrointestinal disorders, through a thorough review of the medical literature. A group of gastroenterologists and experts on nutrition, toxicology, microbiology, and endocrinology reviewed and analyzed the published literature on the topic. The working group formulated conclusions, based on the scientific evidence published, to give an opinion with respect to NCS ingestion. Current evidence does not confirm the carcinogenic potential of NCSs. However, the studies analyzed showed that saccharin could have a proinflammatory effect and that polyols can cause gastrointestinal symptoms and manifestations, depending on the dose and type of compound. The ingestion of xylitol, erythritol, sucralose, aspartame, acesulfame K, and saccharin could increase the secretion of the gastrointestinal hormones that regulate intestinal motility, and stevia and its derivatives could have a favorable effect on the percentage of liver fat. Caution should be taken in recommending aspartame consumption in patients with chronic liver disease because it reduces the ratio of branched-chain amino acids to aromatic amino acids. In addition, NCS ingestion could modify the composition of the intestinal microbiota, having an effect on gastrointestinal symptoms and manifestations. It is important to continue conducting causality studies on humans to be able to establish recommendations on NSC consumption.


Asunto(s)
Enfermedades Gastrointestinales/inducido químicamente , Edulcorantes/efectos adversos , Microbioma Gastrointestinal/efectos de los fármacos , Humanos , Cirrosis Hepática/inducido químicamente , Edulcorantes/farmacología
2.
Am J Orthop (Belle Mead NJ) ; 29(3): 167-73, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10746467

RESUMEN

The management of peripheral nerve injury continues to be a major clinical challenge. Despite advancements in microsurgical technique, results after nerve repair have been unpredictable and dis appointing. The management of these nerve injuries relies on having a thorough understanding of peripheral nerve anatomy. This is the basis of the classification schemes by Seddon and Sunderland, in which the prognosis of nerve injuries varies depending on the degree of injury to their substructures. The most recent advances in the management of peripheral nerve injuries rely on the ability to manipulate the pathophysiologic processes triggered by nerve injuries and regeneration. End-to-end primary repair should be sought whenever a tension-free repair can be attained. If there is a significant nerve gap, use of nerve autograft remains the gold standard. In nerve injuries where a nerve autograft is not possible, the use of nerve allograft, as well as autogenous, biodegradable, and synthetic nerve conduits has shown promising results in experimental studies.


Asunto(s)
Traumatismos de los Nervios Periféricos , Nervios Periféricos/cirugía , Humanos , Procedimientos Neuroquirúrgicos/métodos , Nervios Periféricos/anatomía & histología , Nervios Periféricos/fisiopatología
3.
Horm Res ; 50(4): 217-21, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9838243

RESUMEN

A 15-year-old boy had hypercalcemia in association with malignant retroperitoneal paraganglioma. He had suppressed circulating levels of intact parathyroid hormone, whereas parathyroid hormone-related protein (PTHrP) immunoreactivity was elevated in plasma. Both the serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels were normal. Preoperatively the patient required control of hypercalcemia with intravenous pamidronate therapy. His circulating calcium and PTHrP concentrations became normal after a successful surgical resection of the primary retroperitoneal tumor. To our knowledge, this is the first reported case of elevated PtHrP levels in a patient with paraganglioma which resolved postoperatively.


Asunto(s)
Hipercalcemia/etiología , Paraganglioma/complicaciones , Proteínas/metabolismo , Neoplasias Retroperitoneales/complicaciones , Adolescente , Difosfonatos/uso terapéutico , Humanos , Hipercalcemia/terapia , Masculino , Pamidronato , Paraganglioma/sangre , Paraganglioma/cirugía , Proteína Relacionada con la Hormona Paratiroidea , Neoplasias Retroperitoneales/sangre , Neoplasias Retroperitoneales/cirugía , Tomografía Computarizada por Rayos X
4.
Basic Life Sci ; 60: 89-92, 1993.
Artículo en Inglés | MEDLINE | ID: mdl-8110173

RESUMEN

In the present sample, the Native-American women varied in age (18-60 y) and fatness (23.0-57.4% BF). The cross-validation analysis for %BF estimated by DXA for this sample yielded a high validity coefficient (r = 0.89), and the average %BFDXA (37.3%) and %BFHW (37.6%) did not differ significantly. The prediction error (3.28% BF) was less than the theoretical expected value, given the wide range in age and fatness in this sample. Thus, it appears that DXA may be a viable alternative method for estimating the %BF of a diverse group of Native-American women. The DXA method is more practical than hydrostatic weighing, especially for subjects who are uncomfortable in the water. Also, DXA estimates of bone mineral may lead to improved estimates of FFB density for different ethnic populations.


Asunto(s)
Absorciometría de Fotón , Composición Corporal , Densitometría , Indígenas Norteamericanos , Absorciometría de Fotón/estadística & datos numéricos , Tejido Adiposo/anatomía & histología , Tejido Adiposo/química , Adolescente , Adulto , Agua Corporal/química , Peso Corporal , Densidad Ósea , Densitometría/estadística & datos numéricos , Femenino , Humanos , Persona de Mediana Edad , New Mexico , Reproducibilidad de los Resultados
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA